Protea Biosciences Group Stock Price, News & Analysis (OTCMKTS:PRGB)

$0.04 0.00 (0.00 %)
(As of 01/19/2018 04:00 PM ET)
Previous Close$0.04
Today's Range$0.04 - $0.04
52-Week Range$0.01 - $7.75
Average Volume2,282 shs
Market Capitalization$81,800.00
P/E Ratio0.00
Dividend YieldN/A

About Protea Biosciences Group (OTCMKTS:PRGB)

Protea Biosciences Group, Inc. is a molecular information company. The Company is engaged in developing and commercializing life science technologies, products and services to identify the molecules that are produced by living cells and all life forms. It also offers a platform technology, Laser Ablation Electrospray Ionization (LAESI), which enables the direct analysis, mapping and display of molecular information in living cells and tissue samples. The Company's commercial development is centered in three business lines: Molecular Information Services, LAESI Instruments, Software and Consumables, and Molecular Diagnostics and Clinical Research. Its services enable the identification and quantitation of both small molecules (lipids and metabolites) and large molecules (proteins) and the services portfolio, inclusive of mass spectrometry imaging (MSI), proteomics, metabolomics, lipidomics and bioinformatics. Its clients include pharmaceutical, chemical and biotechnology companies.

Receive PRGB News and Ratings via Email

Sign-up to receive the latest news and ratings for PRGB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology


Debt-to-Equity Ratio-0.15%
Current Ratio0.04%
Quick Ratio0.04%


Trailing P/E Ratio-0.00484764542936288
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.45 million
Price / Sales0.11
Cash FlowN/A
Price / CashN/A
Book Value($4.34) per share
Price / Book-0.01


Trailing EPS($7.22)
Net Income$-15,640,000.00
Net Margins-1,676.78%
Return on EquityN/A
Return on Assets-805.49%


Outstanding Shares7,970,000

Protea Biosciences Group (OTCMKTS:PRGB) Frequently Asked Questions

What is Protea Biosciences Group's stock symbol?

Protea Biosciences Group trades on the OTCMKTS under the ticker symbol "PRGB."

How were Protea Biosciences Group's earnings last quarter?

Protea Biosciences Group Inc (OTCMKTS:PRGB) issued its earnings results on Tuesday, November, 18th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.05) by $0.02. The company earned $0.52 million during the quarter, compared to the consensus estimate of $0.46 million. View Protea Biosciences Group's Earnings History.

Who are some of Protea Biosciences Group's key competitors?

Who are Protea Biosciences Group's key executives?

Protea Biosciences Group's management team includes the folowing people:

  • Matthew Powell Ph.D., , Chief Scientific Officer, Vice President - Research & Development (Age 40)
  • Stanley Hostler, Vice President, Secretary, Director (Age 87)
  • Josiah T. Austin, Independent Director (Age 68)
  • Leonard Harris, Independent Director (Age 79)
  • Edwin S Roberson, Independent Director (Age 70)
  • Scott Segal, Independent Director (Age 60)

How do I buy Protea Biosciences Group stock?

Shares of Protea Biosciences Group can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Protea Biosciences Group's stock price today?

One share of Protea Biosciences Group stock can currently be purchased for approximately $0.04.

How big of a company is Protea Biosciences Group?

Protea Biosciences Group has a market capitalization of $81,800.00 and generates $2.45 million in revenue each year. The company earns $-15,640,000.00 in net income (profit) each year or ($7.22) on an earnings per share basis. Protea Biosciences Group employs 25 workers across the globe.

How can I contact Protea Biosciences Group?

Protea Biosciences Group's mailing address is 1311 Pineview Dr Ste 501, MORGANTOWN, WV 26505-3276, United States. The company can be reached via phone at +1-304-2922226.

MarketBeat Community Rating for Protea Biosciences Group (PRGB)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  27 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  58
MarketBeat's community ratings are surveys of what our community members think about Protea Biosciences Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Protea Biosciences Group (OTCMKTS:PRGB) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Protea Biosciences Group (OTCMKTS:PRGB) Earnings History and Estimates Chart

Earnings by Quarter for Protea Biosciences Group (OTCMKTS:PRGB)

Protea Biosciences Group (OTCMKTS PRGB) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/18/2014($0.05)($0.07)$0.46 million$0.52 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Protea Biosciences Group (OTCMKTS:PRGB) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Protea Biosciences Group (OTCMKTS:PRGB)

No dividend announcements for this company have been tracked by

Insider Trades

Protea Biosciences Group (OTCMKTS PRGB) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 31.90%
Institutional Ownership Percentage: 3.39%
Insider Trades by Quarter for Protea Biosciences Group (OTCMKTS:PRGB)

Protea Biosciences Group (OTCMKTS PRGB) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/3/2016Stanley HostlerDirectorBuy293,333$0.08$23,466.64View SEC Filing  
7/25/2016Stephen C TurnerCEOBuy20,000$0.15$3,000.002,197,372View SEC Filing  
7/5/2016Stephen C TurnerCEOBuy24,000$0.15$3,600.002,177,372View SEC Filing  
(Data available from 1/1/2013 forward)


Protea Biosciences Group (OTCMKTS PRGB) News Headlines


SEC Filings

Protea Biosciences Group (OTCMKTS:PRGB) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


Protea Biosciences Group (OTCMKTS PRGB) Stock Chart for Saturday, January, 20, 2018

Loading chart…

This page was last updated on 1/20/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.